In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[EX Q]: Genetic Information Nondiscrimination in Health Insurance Act of 1997 - Amends the Employee Retirement Income Security Act of 1974 to prohibit a group health plan or a health insurance issuer offering group coverage from discriminating on the basis:  (1) of genetic information; or (2) that the participant or beneficiary has requested or received genetic services.  Regulates genetic information collection and disclosure by plans and issuers.  Provides for compensatory, consequential, and punitive damages. 
Amends the Public Health Service Act to prohibit a group health plan, a health insurance issuer offering group coverage, or a health issuer in the individual market from so discriminating.  Regulates genetic information collection and disclosure by plans and issuers.  Provides for compensatory, consequential, and punitive damages. 
Amends title XVIII (Medicare) of the Social Security Act to prohibit an issuer of a Medicare supplemental policy from so discriminating.  Provides for compensatory, consequential, and punitive damages. 
Amends the Internal Revenue Code to prohibit a group health plan or a health insurance issuer offering group coverage from so discriminating.  Regulates genetic information collection and disclosure by plans and issuers.
[EX A]: Genetic Information Nondiscrimination in Health Insurance Act of 1997

[EX Q]: Angie Fatino Save Our Children from Meth Act of 2005 - Amends the Controlled Substances Act to direct the Attorney General to transfer to schedule V ephedrine, pseudoephedrine, and phenylpropanolamine. Makes this provision inapplicable with respect to pseudoephedrine when contained in a product that is in a liquid, liquid capsule, or liquid-filled gel capsule, that does not contain more than 360 milligrams of pseudoephedrine, and that is approved under the Federal Food, Drug, and Cosmetic Act (pseudoephedrine contained in such product shall then be considered a list I chemical).

Revises the definition of "regulated transaction" to exclude specified transactions involving drugs or products that the Attorney General determines are being diverted for illicit purposes.

Places restrictions on the sale of list I and schedule V pseudoephedrine products. Requires a registrant of list I products to: (1) place the products where the customers do not have direct access to them; (2) maintain a sales logbook that identifies the products, purchasers, dates, and times of sales; and (3) not sell such a product to persons under age 18. Prohibits a registrant of schedule V products that do not require prescriptions from dispensing such a product to a prospective purchaser under age 18.

Sets penalties for violations.

Prohibits any person from knowingly or intentionally purchasing at retail: (1) more than one list I pseudoephedrine product during a 24-hour period without a prescription; (2) more than 7,500 milligrams of pseudoephedrine in list I or schedule V products during a 30-day period without a prescription; or (3) such a list I product without legibly signing the appropriate logbook.
[EX A]: To amend the Controlled Substances Act to provide for the transfer of ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances, and for other purposes.

[EX Q]: TABLE OF CONTENTS: 
     Title I:  National Science Foundation Authorization 
     Title II:  General Provisions 
National Science Foundation Authorization Act of 1995 - 
Title I: National Science Foundation Authorization
 - Authorizes appropriations to the National Science Foundation (NSF) for FY 1996 and 1997. 
(Sec. 104) Provides for reprogramming of appropriations. 
(Sec. 105) States that nothing in this Act shall preclude additional FY 1996 authorization of appropriations for NSF. 
Title II:  General Provisions
 - Amends the National Science Foundation Act of 1950 to direct NSF to include in its annual report to the President a strategic plan defining its goals, criteria, and procedures. 
(Sec. 202) Requires NSF to submit to the Congress an annual upgrade and maintenance plan for national research facilities. 
(Sec. 203) Amends the Academic Research Facilities Modernization Act of 1988 to give research facility grant priority to institutions or consortia that have not received such funds in the preceding five years. 
(Sec. 204) Makes administrative amendments to the National Science Foundation Act of 1950, the National Science Foundation Authorization Act, 1976, the National Science Foundation Authorization Act of 1988, and the Education for Economic Security Act. 
(Sec. 206) Requires certain research instrumentation and facilities guidelines to be incorporated in NSF grant notices. 
(Sec. 207) Subjects NSF temporary employees to the same financial disclosure requirements as apply to permanent employees. 
(Sec. 208) Requires an institution of higher education receiving NSF funds to grant a military-educational leave of absence to a student on active military duty (other than training). 
(Sec. 209) Prohibits the use of any funds authorized under this Act from being used for any lobbying activity. 
(Sec. 210) Renames the Critical Technologies Institute as the Science Studies Institute. 
(Sec. 211) Requires NSF to consider the impact of a grant on undergraduate and graduate education before its award. 
(Sec. 212) Authorizes the Director of NSF to appoint up to six Assistant Directors. 
(Sec. 214) Excludes from NSF awards for five years any person who received project funds not subject to competitive merit-based awards. (Exempts persons who are members of a law-specified class.)
[EX A]:
National Science Foundation Authorization Act of 1995